Houston, TX, United States of America

Baldwin H Tom

This inventor holds 1 USPTO granted patent. Top assignee: Northwestern University. Active years: 1980.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Baldwin H Tom. Retrieved from https://idiyas.com/inventor/baldwin-h-tom-utbn4eq6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1980

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Baldwin H Tom: Innovator in Carcinoembryonic Antigen Production

Introduction

Baldwin H Tom is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of medical research, particularly in the production of carcinoembryonic antigen (CEA). His work has implications for cancer diagnostics and treatment.

Latest Patents

Baldwin H Tom holds 1 patent for a process of producing carcinoembryonic antigen. This patent details the in vitro production of CEA from the cell lines LS-180 and LS-174T, along with cells derived from these lines. The CEA produced can serve as a standard source for radioimmunoassay procedures, which are essential for determining CEA plasma levels in patients.

Career Highlights

Baldwin H Tom is affiliated with Northwestern University, where he has been involved in groundbreaking research. His work has contributed to advancements in cancer diagnostics, enhancing the ability to monitor and treat patients effectively.

Collaborations

He has collaborated with notable colleagues, including Milda M Jakstys and Barry D Kahan. These partnerships have fostered a collaborative environment that promotes innovation and research excellence.

Conclusion

Baldwin H Tom's contributions to the field of carcinoembryonic antigen production highlight his role as an important inventor in medical research. His work continues to impact cancer diagnostics and treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…